These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5269283)

  • 1. [The thrombin generation test and heparin overloading in normal subjects and patients with arteriosclerosis].
    Karaca M; Kabamçi T; Göksel V
    Rev Med Moyen Orient; 1967; 24(4):287-91. PubMed ID: 5269283
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Heparin thrombin clotting-time and platelet factor 4.
    O'Brien JR; Etherington M; Jamieson S; Lawford P
    Lancet; 1974 Sep; 2(7881):656-7. PubMed ID: 4137779
    [No Abstract]   [Full Text] [Related]  

  • 3. The recalcified coagulation activity.
    Stief TW
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):447-53. PubMed ID: 18160574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extrinsic coagulation activity assay.
    Stief TW; Wieczerzak A; Renz H
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):303-18. PubMed ID: 18586682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of thrombin generation in whole blood--the effect of heparin and aspirin.
    Kessels H; Béguin S; Andree H; Hemker HC
    Thromb Haemost; 1994 Jul; 72(1):78-83. PubMed ID: 7974380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring thrombin generation based sensitivity to activated protein C using an automated coagulometer (ACL 9000).
    Gardiner C; Machin SJ; Mackie IJ
    Int J Lab Hematol; 2008 Aug; 30(4):261-8. PubMed ID: 18665822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring complex formation in the blood-coagulation cascade using aptamer-coated SAW sensors.
    Gronewold TM; Glass S; Quandt E; Famulok M
    Biosens Bioelectron; 2005 Apr; 20(10):2044-52. PubMed ID: 15741074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro thrombogenicity tests of factor IX concentrates. II: effects of phospholipids and heparin.
    Prowse CV; Boffa MC; Guthrie C; Pepper DS
    Thromb Haemost; 1980 Feb; 42(5):1368-77. PubMed ID: 7368144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Heparin resistance in patients with coronary artery disease.
    Svehla C
    Atherosclerosis; 1973; 18(3):509-12. PubMed ID: 4751230
    [No Abstract]   [Full Text] [Related]  

  • 10. Do we need a better test? Can thrombin generation be useful?
    Aledort LM
    Curr Hematol Rep; 2004 Mar; 3(2):75-6. PubMed ID: 14965481
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of heparin on osmotic resistance of erythrocytes in normal subjects and in patients with coronary arteriosclerosis].
    Babei E; Ungureanu E; Cristea E
    Stud Cercet Med Interna; 1970; 11(1):61-6. PubMed ID: 5455847
    [No Abstract]   [Full Text] [Related]  

  • 12. The anticoagulant capacity of plasmatic unfractionated heparin decreases at 23 degrees C.
    Stief TW
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):209-12. PubMed ID: 17287642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin cofactor deficiency and instability as reflected by the 24-hour heparin clot inhibition test.
    Koszewski BJ; Powell LW; Vahabzadeh H
    Vasc Dis; 1968 Sep; 5(3):152-64. PubMed ID: 5676640
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of the surface on thrombin generation.
    Stief TW
    Int J Lab Hematol; 2008 Aug; 30(4):269-77. PubMed ID: 18665823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative data on the coaguability of blood in hypertensive disease and arteriosclerosis].
    Libenson RT
    Kardiologiia; 1970 Oct; 10(10):135-6. PubMed ID: 5504108
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Control of heparin and oral anticoagulants, with micromethods: thrombin time, quick determination with addition of protamine].
    Seiler K; Müller G; Duckert F
    Schweiz Med Wochenschr; 1970 Sep; 100(36):1522-8. PubMed ID: 5524716
    [No Abstract]   [Full Text] [Related]  

  • 18. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time.
    al Dieri R; Alban S; Béguin S; Hemker HC
    J Thromb Haemost; 2004 Aug; 2(8):1395-401. PubMed ID: 15304046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ; Joist JH
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.